Pro-Dex (PDEX) Competitors $32.69 -1.12 (-3.31%) Closing price 04:00 PM EasternExtended Trading$32.75 +0.06 (+0.18%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PDEX vs. TMCI, CBLL, SMLR, DCTH, BFLY, RXST, CARL, SNWV, NPCE, and CLPTShould you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include Treace Medical Concepts (TMCI), CeriBell (CBLL), Semler Scientific (SMLR), Delcath Systems (DCTH), Butterfly Network (BFLY), RxSight (RXST), Carlsmed (CARL), Sanuwave Health (SNWV), NeuroPace (NPCE), and ClearPoint Neuro (CLPT). These companies are all part of the "medical equipment" industry. Pro-Dex vs. Its Competitors Treace Medical Concepts CeriBell Semler Scientific Delcath Systems Butterfly Network RxSight Carlsmed Sanuwave Health NeuroPace ClearPoint Neuro Treace Medical Concepts (NASDAQ:TMCI) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment. Is TMCI or PDEX more profitable? Pro-Dex has a net margin of 13.48% compared to Treace Medical Concepts' net margin of -23.01%. Pro-Dex's return on equity of 26.67% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-23.01% -46.76% -23.35% Pro-Dex 13.48%26.67%14.95% Do analysts recommend TMCI or PDEX? Treace Medical Concepts presently has a consensus target price of $9.83, suggesting a potential upside of 39.68%. Pro-Dex has a consensus target price of $56.00, suggesting a potential upside of 71.31%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts clearly believe Pro-Dex is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Pro-Dex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, TMCI or PDEX? Treace Medical Concepts has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, Pro-Dex has a beta of -0.04, meaning that its stock price is 104% less volatile than the S&P 500. Does the media favor TMCI or PDEX? In the previous week, Pro-Dex had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 2 mentions for Pro-Dex and 0 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.92 beat Pro-Dex's score of 0.49 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Overall Sentiment Treace Medical Concepts Positive Pro-Dex Neutral Which has higher valuation and earnings, TMCI or PDEX? Pro-Dex has lower revenue, but higher earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$209.36M2.12-$55.74M-$0.79-8.91Pro-Dex$66.59M1.60$8.98M$2.7012.11 Do institutionals and insiders hold more shares of TMCI or PDEX? 84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 27.7% of Treace Medical Concepts shares are owned by insiders. Comparatively, 47.5% of Pro-Dex shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryPro-Dex beats Treace Medical Concepts on 10 of the 16 factors compared between the two stocks. Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PDEX vs. The Competition Export to ExcelMetricPro-DexMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$110.29M$16.91B$5.75B$10.32BDividend YieldN/A1.57%5.89%4.63%P/E Ratio12.1116.9057.4022.66Price / Sales1.602.29519.99119.25Price / Cash10.7812.8337.2260.63Price / Book2.913.3113.946.31Net Income$8.98M$472.94M$3.29B$271.37M7 Day Performance-8.43%-2.33%0.63%2.11%1 Month Performance-23.50%-6.53%4.32%6.67%1 Year Performance32.08%1.56%84.13%27.84% Pro-Dex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PDEXPro-Dex2.6345 of 5 stars$32.69-3.3%$56.00+71.3%+19.1%$110.29M$66.59M12.11140Gap UpTMCITreace Medical Concepts2.3898 of 5 stars$7.11-0.8%$9.83+38.3%+41.1%$452.95M$209.36M-9.00250Positive NewsCBLLCeriBell2.531 of 5 stars$12.06+2.2%$32.14+166.5%N/A$432.64M$65.44M-4.03N/APositive NewsSMLRSemler Scientific2.9653 of 5 stars$28.29+0.6%$81.75+189.0%+14.5%$416.31M$56.29M11.64120DCTHDelcath Systems3.0621 of 5 stars$11.55-0.9%$24.50+112.1%+16.0%$407.53M$37.21M231.0060Positive NewsBFLYButterfly Network3.3406 of 5 stars$1.60+2.2%$3.00+88.1%-10.7%$392.72M$82.06M-5.70460RXSTRxSight1.9419 of 5 stars$8.94+0.6%$10.00+11.9%-83.7%$363.74M$139.93M-11.18220Trending NewsCARLCarlsmedN/A$13.38+5.0%N/AN/A$338.64MN/A0.00100Positive NewsSNWVSanuwave Health2.5327 of 5 stars$35.92-5.2%$55.00+53.1%N/A$324.56M$32.63M-4.3540Positive NewsNPCENeuroPace3.1916 of 5 stars$9.71-0.2%$16.60+71.0%+40.6%$321.88M$79.91M-11.56170Positive NewsCLPTClearPoint Neuro1.9068 of 5 stars$10.93-1.1%$19.67+79.9%-14.1%$314.12M$31.39M-13.49110 Related Companies and Tools Related Companies TMCI Competitors CBLL Competitors SMLR Competitors DCTH Competitors BFLY Competitors RXST Competitors CARL Competitors SNWV Competitors NPCE Competitors CLPT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PDEX) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
